Guava Technologies has announced an exclusive partnership with IMV Technologies to provide breeders and scientists with a cellular analysis platform that enables evaluation of fertility parameters.
Performing a panel of simple proprietary tests on an IMV/Guava Easycyte Mini or IMV/Guava Easycyte Plus microcapillary flow cytometer delivers a better understanding of sperm cell physiological status, enabling artificial insemination centres to better manage semen production and sires.
'Working closely with IMV Technologies we have produced a platform that represents a paradigm shift in animal semen quality control,' said Paul Wheeler, vice president of sales and marketing for Guava Technologies.
'The levels of accuracy, reproducibility and productivity are due to the attributes of our microcapillary flow cytometers and development of discriminating tests for sperm cell viability, motility, capacitation, acrosomal integrity, DNA fragmentation and bacterial contamination by IMV Technologies.' Guava Technologies said that these microcapillary flow cytometers accommodate smaller sample volumes, generate less waste, have lower operating costs, and are easier to set up and maintain than the typical flow cytometer.
Using the attributes of microcapillary-based flow cytometry, the company's integrated systems enable scientists and clinicians not specialised in the technology to perform complex cellular analyses directly from their own lab.
